Kura Oncology COO Kathleen Ford Sells Stock Under 10b5-1 Plan Amid Market Volatility
Kathleen Ford, Chief Operating Officer of Kura Oncology (NASDAQ:KURA), executed a sale of company stock totaling $20,482. This transaction occurred despite the underlying stock experiencing significant gains over the past year and in the most recent week. The selling was conducted through an established Rule 10b5-1 trading plan. Separately, Kura On…